TITLE

Antimicrobial Approaches for Preventing Infections Associated with Surgical Implants

AUTHOR(S)
Darouiche, Rabih O.
PUB. DATE
May 2003
SOURCE
Clinical Infectious Diseases;5/15/2003, Vol. 36 Issue 10, p1284
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Because management of infections associated with surgical implants can be both difficult and costly, prevention of such infections remains a priority. Preventive strategies comprise systemic perioperative administration of antibiotics and local application of antimicrobial agents (antibiotics or antiseptics). Local antimicrobial prophylaxis can be provided in various forms and aims to prevent implant-associated infections by impeding bacterial adherence to the implant surface and/or reducing the concentration of bacteria in the immediate vicinity of the implant. Analysis of the existing clinical practices and the pertinent medical literature indicates that, although some antimicrobial strategies constitute the standard of care for preventing infections associated with surgical implants, such strategies are often applied in a nonstandardized fashion and without clear evidence of clinical efficacy. This review article concludes with a perspective on assessing and preventing such serious infections.
ACCESSION #
9768970

 

Related Articles

  • Bioactive Coating of Titanium Surfaces with Recombinant Human β -Defensin- 2 (rHuβD2) May Prevent Bacterial Colonization in Orthopaedic Surgery. Pfeufer, Nadine Y.; Hofmann-Peiker, Karsten; Muhle, Mike; Warnke, Patrick H.; Weigel, Martin C.; Kleine, Michael // Journal of Bone & Joint Surgery, American Volume;5/4/2011, Vol. 93-A Issue 9, p840 

    Background: A promising strategy to prevent infections around orthopaedic titanium implants is to use naturally occurring cationic antimicrobial peptides (CAMPs) such as, the human β-defensin-2 as antibacterial coatings. Human antimicrobial peptides represent a part of the innate immune...

  • BEATING THE BUGS. Conlan, Michael F. // Drug Topics;2/5/2001, Vol. 145 Issue 3, p16 

    Reports on the plans of the United States government to combat the rising threat of antimicrobial resistance (AR). Risks of AR; Components of the plan; How the government intends to enhance infection control in health settings.

  • Broad-ranging campaign strives to combat antibiotic resistance.  // Geriatrics;Sep2000, Vol. 55 Issue 9, p29 

    Deals with the nationwide strategy of federal agencies to fight antimicrobial resistance in the United States. Purpose of the campaign; Promotion of vaccination to prevent infections; Application of computer-assisted physician-support programs for anti-infective agents.

  • Hospitals use new anti-bacterial spray and wipes to reduce infection.  // Operating Theatre Journal;May2012, Issue 260, p6 

    The article offers brief information on the Micro-Fresh, a spray and disposable surface wipes, from Micro-Fresh.

  • American Journal of Infection Control: Infection prevention groups outline steps needed to preserve antibiotics.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article offers information on the role of infection preventionists and health care epidemiologists in promotion of effective antimicrobial stewardship.

  • Understanding the Spread of Antibiotic Resistant Pathogens in Hospitals: Mathematical Models as Tools for Control. Bonten, Marc J.M.; Austin, Daren J.; Lipsitch, Marc // Clinical Infectious Diseases;11/15/2001, Vol. 33 Issue 10, p1739 

    As microorganisms become more resistant to antimicrobial agents, effective infection control measures will become increasingly important. However, despite multiple studies on infection prevention, few data exist on the quantitative effects of the individual aspects of infection control...

  • Microbicide Gel Fails to Protect.  // VAX;Dec2009, Vol. 7 Issue 12, p3 

    The article offers information on the microbicide research regarding a gel known as PRO 2000 which failed to prevent human immunodeficiency virus infection in a Phase III efficacy trial of 9,385 women in Great Britain, Tanzania, South Africa, Zambia and Uganda.

  • Hypochlorous Acid - Analytical Methods and Antimicrobial Activity. Eryılmaz, Müjde; Palabıyık, İsmail Murat // Tropical Journal of Pharmaceutical Research;Feb2013, Vol. 12 Issue 1, p123 

    Hypochlorous acid (HOCl) is produced by the human body's immune cells to fight infections. It is effective against a broad range of microorganisms. It is non-toxic, non-irritant and non-corrosive at proper usage concentrations. There are some available commercial products that contain HOCl....

  • antiseptic (Major drug group).  // Royal Society of Medicine: Medicines;2002, p79 

    The article presents information on antiseptic agents. These agents destroy micro-organisms or inhibit their activity to such an extent that they are less, or no longer, harmful to health. Antiseptics can be applied to the skin, burns or wounds to prevent infections and to limit the spread of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics